Saba Alzabin
Co-Founder and Chief Scientific Officer, Nabta Health
Immunologist experienced in biomarker discovery and early clinical assessment, Saba is building the world's first hybrid healthcare platform that utilises digital technology to improve diversity in datasets, and pave way for inclusive, transparent and truly personalised healthcare.